• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以离体灌注肠段为模型,了解胰高血糖素样肽-1的释放机制和分泌模式。

Understanding the release mechanisms and secretion patterns for glucagon-like peptide-1 using the isolated perfused intestine as a model.

作者信息

Galsgaard Katrine D, Modvig Ida M, Holst Jens J

机构信息

Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

出版信息

Biochem Soc Trans. 2025 Jan 31;53(1):BST20241062. doi: 10.1042/BST20241062.

DOI:10.1042/BST20241062
PMID:39887325
Abstract

In the gastrointestinal (GI) tract, food is digested and absorbed while GI hormones are secreted from the enteroendocrine cells (EECs). These hormones regulate food intake, glucose homeostasis, digestion, GI motility, and metabolism. Although ECCs may express more than a single hormone, the ECCs usually secrete only one or a few hormones. The pattern of EEC secretion varies along the length of the GI tract as the different EEC types are scattered in different densities along the GI tract. Following bariatric surgery, a postprandial hypersecretion of certain GI hormones occurs which contributes to the postsurgery weight loss. Mimicking this postprandial hypersecretion of GI hormones by targeting endogenous EEC secretion, using specific modulators of receptors, ion channels, and transporters found on specific EECs, to induce weight loss is a current research aim. To achieve this, a more complete understanding of the release mechanisms, expression of receptors, transporters, and the secretion pattern of the different ECC types is needed. Using the vascularly perfused intestinal model, it is possible to obtain a detailed knowledge of these release mechanisms by evaluating the effects on secretion of blocking or stimulating specific receptors, ion channels, and transporters as well as evaluating nutrient handling and absorption in each of the different sections of the intestine. This mini-review will focus on how the isolated perfused intestine has been used in our group as a model to investigate the nutrient-induced release mechanisms of ECCs with a focus on glucagon-like peptide-1 secreting cells.

摘要

在胃肠道中,食物被消化和吸收,同时胃肠道激素从肠内分泌细胞(EECs)分泌出来。这些激素调节食物摄入、葡萄糖稳态、消化、胃肠蠕动和新陈代谢。虽然肠内分泌细胞可能表达不止一种激素,但通常只分泌一种或几种激素。随着不同类型的肠内分泌细胞沿胃肠道以不同密度分布,其分泌模式沿胃肠道长度而变化。减肥手术后,会出现某些胃肠道激素的餐后分泌过多,这有助于术后体重减轻。通过靶向内源性肠内分泌细胞分泌,使用在特定肠内分泌细胞上发现的受体、离子通道和转运体的特异性调节剂来模拟胃肠道激素的这种餐后分泌过多以诱导体重减轻是当前的研究目标。为实现这一目标,需要更全面地了解不同类型肠内分泌细胞的释放机制、受体、转运体的表达以及分泌模式。利用血管灌注肠模型,通过评估阻断或刺激特定受体、离子通道和转运体对分泌的影响以及评估肠道不同节段的营养物质处理和吸收情况,可以详细了解这些释放机制。本综述将重点关注在我们小组中,离体灌注肠作为模型如何用于研究营养物质诱导的肠内分泌细胞释放机制,重点是分泌胰高血糖素样肽-1的细胞。

相似文献

1
Understanding the release mechanisms and secretion patterns for glucagon-like peptide-1 using the isolated perfused intestine as a model.以离体灌注肠段为模型,了解胰高血糖素样肽-1的释放机制和分泌模式。
Biochem Soc Trans. 2025 Jan 31;53(1):BST20241062. doi: 10.1042/BST20241062.
2
Intestinal enteroendocrine cells rely on ryanodine and IP calcium store receptors for mechanotransduction.肠内分泌细胞依赖于 Ryanodine 和 IP3 钙储存受体进行机械转导。
J Physiol. 2023 Jan;601(2):287-305. doi: 10.1113/JP283383. Epub 2022 Dec 13.
3
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
4
Integration of signal transduction pathways in sensory epithelial enteroendocrine cells.感觉上皮肠内分泌细胞中信号转导通路的整合
Mol Biol Cell. 2025 Jun 1;36(6):re3. doi: 10.1091/mbc.E24-03-0143.
5
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.

本文引用的文献

1
Single-cell transcriptomic atlas of enteroendocrine cells along the murine gastrointestinal tract.单细胞转录组图谱沿著小鼠胃肠道的肠内分泌细胞。
PLoS One. 2024 Oct 8;19(10):e0308942. doi: 10.1371/journal.pone.0308942. eCollection 2024.
2
A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point?GLP-1 受体激动剂与减重手术的成本比较:平衡点在哪里?
Surg Endosc. 2024 Nov;38(11):6560-6565. doi: 10.1007/s00464-024-11191-1. Epub 2024 Sep 16.
3
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial.
每周一次司美格鲁肽 2.4 毫克治疗肥胖症和糖尿病前期患者的疗效和安全性(STEP 10):一项随机、双盲、安慰剂对照、多中心 3 期临床试验。
Lancet Diabetes Endocrinol. 2024 Sep;12(9):631-642. doi: 10.1016/S2213-8587(24)00182-7. Epub 2024 Jul 29.
4
L-valine is a powerful stimulator of GLP-1 secretion in rodents and stimulates secretion through ATP-sensitive potassium channels and voltage-gated calcium channels.L-缬氨酸是一种强有力的 GLP-1 分泌刺激物,可通过 ATP 敏感性钾通道和电压门控钙通道刺激分泌。
Nutr Diabetes. 2024 Jun 11;14(1):43. doi: 10.1038/s41387-024-00303-4.
5
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.司美格鲁肽对 2 型糖尿病患者慢性肾脏病的影响。
N Engl J Med. 2024 Jul 11;391(2):109-121. doi: 10.1056/NEJMoa2403347. Epub 2024 May 24.
6
Acute pharmacodynamic responses to sitagliptin: Drug-induced increase in early insulin secretion in oral glucose tolerance test.西他列汀的急性药效学反应:口服葡萄糖耐量试验中药物诱导的早期胰岛素分泌增加。
Clin Transl Sci. 2024 May;17(5):e13809. doi: 10.1111/cts.13809.
7
Targeting the GLP-2 receptor in the management of obesity.针对肥胖症管理中的 GLP-2 受体。
Peptides. 2024 Jul;177:171210. doi: 10.1016/j.peptides.2024.171210. Epub 2024 Apr 3.
8
New Lessons from the gut: Studies of the role of gut peptides in weight loss and diabetes resolution after gastric bypass and sleeve gastrectomy.肠道的新启示:研究肠肽在胃旁路和袖状胃切除术后减肥和糖尿病缓解中的作用。
Peptides. 2024 Jun;176:171199. doi: 10.1016/j.peptides.2024.171199. Epub 2024 Mar 27.
9
In Vivo Inhibition of Dipeptidyl Peptidase 4 Allows Measurement of GLP-1 Secretion in Mice.体内抑制二肽基肽酶 4 可用于测量小鼠中 GLP-1 的分泌。
Diabetes. 2024 May 1;73(5):671-681. doi: 10.2337/db23-0848.
10
Cellular mechanisms of incretin hormone secretion.肠促胰岛素激素分泌的细胞机制。
J Mol Endocrinol. 2024 Feb 22;72(4). doi: 10.1530/JME-23-0112. Print 2024 May 1.